Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$4.80 USD

4.80
1,810

0.00 (0.00%)

Updated Jun 18, 2026 03:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (152 out of 247)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Masimo (MASI) Announces Favorable Study Results on SpHb

by Zacks Equity Research

Masimo's (MASI) SpHb is likely to enhance perioperative transfusion management and post-operative patient outcomes on pediatric patients.

Zacks Equity Research

Reasons to Retain Intuitive Surgical (ISRG) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.

Zacks Equity Research

Are You Looking for a Top Momentum Pick? Why AllScripts Healthcare (MDRX) is a Great Choice

by Zacks Equity Research

Does AllScripts Healthcare (MDRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Is Lantheus Holdings (LNTH) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Lantheus Holdings (LNTH) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.

Zacks Equity Research

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and strategic deals.

Zacks Equity Research

HealthEquity (HQY) Q4 Earnings Lag Estimates, Margins Down

by Zacks Equity Research

HealthEquity (HQY) witnesses solid growth in HSAs, along with recording robust Custodial and Interchange revenues, in the fourth quarter of fiscal 2022.

Zacks Equity Research

Reasons to Add Allscripts (MDRX) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.

Zacks Equity Research

Catalent's (CTLT) New Project Completion Expands Global Footprint

by Zacks Equity Research

Catalent's (CTLT) latest facility transformation is likely to significantly enhance the global Biologics business.

Zacks Equity Research

Masimo's (MASI) New Product Expansion to Boost Patient Outcome

by Zacks Equity Research

Masimo's (MASI) latest feature additions to its telehealth for Patient SafetyNet are likely to significantly improve patient outcomes.

Zacks Equity Research

Medtronic (MDT) Boosts Surgical Robotics Wing With New Deal

by Zacks Equity Research

According to Medtronic (MDT), Touch Surgery Enterprise is the first AI-powered platform of its kind for the operating room (OR). It is compatible with Medtronic's Hugo robotic-assisted surgery (RAS) system.